Study indicates potential danger from aspirin/hormone therapy mix Cubist acquires Illumigen in potential $341.5 million deal Teva launches generic Protonix, Wyeth heads to court to claim damages FDA issues Wyeth approvable letter for bazedoxifene Stake in drug-testing contractor purchased in $3 billion-plus deal Pfizer receives FDA approvable letter for dalbavancin Senate passes Medicare, SCHIP bill, but misses I.T. mandate CDC says doctors should postpone final Hib vaccine due to shortage Jazz, Solvay receive approvable letter from FDA regarding extended-release Luvox FDA stresses safety information for fentanyl patch First Previous 2607 2608 2609 2610 2611 Next Last